Techdamentals

Cronos Group Inc. (CRON) intrinsic value

A fair-value range from four valuation models. Healthcare.
$3.38 OVERVALUED
22.9% above the weighted fair value of $2.75
After hours $3.38 ▼ 0.01% (not used in the valuation)
Model estimate: $2.62Model estimate: $2.95 $3.38 $2.48 $3.03
Fair value range calculated August 29, 2026 from reported financials. Price is live, and the verdict is measured against today's price.

Tell me if CRON stops being expensive

It trades above our fair-value range today. We will email you if it falls back into it. Free account to start, then Pro $10/mo for alerts. Cancel anytime.

Create a free account →
Limited offer
20% off your first year — use code at checkout. For the next 25 subscribers. See the plans →

Or look up your own

Any ticker, the same four models. Three complete analyses free, no card. Pro makes it unlimited and adds alerts.

Run a ticker →

What this range means

Cronos Group Inc. (CRON) has an estimated fair value range of $2.48 to $3.03, calculated on August 29, 2026. 2 of the four valuation models applied to this company. The individual models landed between $2.62 and $2.95, and the range above is built around their weighted average of $2.75. A range rather than a single figure is the honest output here: each model rests on different assumptions about growth and profitability, so where they disagree is itself information. A wide spread means the models see this company differently; a narrow one means they broadly agree.

How these models are calculated · What each term means

What an account adds

This page is the headline. The calculator shows the working.
●
All four valuation models
Each estimate side by side, how they are weighted, and where they disagree
●
Key takeaways
What the numbers mean for this company, in plain English
●
Year-by-year projections
The cash flows the estimate is built from, year by year
●
The full input data grid
Every figure feeding the models, with its source and a validation check
●
Reverse valuation
What growth rate today’s price already assumes
●
Your own assumptions
Override any input and re-run the whole analysis
●
Twelve months of price history
Charted against the fair-value range
●
Watchlist and alerts
An email when price crosses the range
Every company we have analysed, in one list
The Fair Value Screener sorts every published company by how far price sits from the calculated range, each row dated. It is an ordering of the same math this page shows, not a list of suggestions.
The first ten rows are open to everyone. Pro opens the rest.
See the Fair Value Screener →
ReadR comes with Pro
The second app on the same account. Upload any chart and get a plain-English read of what it shows. Three reads free, unlimited on Pro.
See ReadR →

Other analyses

PYPLPLTRMNDYINODAMDGOOGLVRTFLEXCRDONVDAAFRMMRVL
Educational tool, not investment advice. These are automated estimates from third-party data, impersonal and not tailored to anyone's situation. Data can be inaccurate and model assumptions can be wrong. We are not a registered investment adviser or broker-dealer. Always do your own research. See our methodology and terms.